| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/07/2009 | EP2011512A1 An anti HSP90 antibody |
| 01/07/2009 | EP2011511A2 Pharmaceutical composition containing the nmb0938 protein |
| 01/07/2009 | EP2011510A2 Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments |
| 01/07/2009 | EP2011509A2 Pharmaceutical composition containing the nmb0606 protein |
| 01/07/2009 | EP2011508A1 Use of trap protein as active ingredient for manufacturing a medicament for the treatment of staphylococcus aureus infection |
| 01/07/2009 | EP2010911A2 Treatment of tumors expressing mutant egf receptors |
| 01/07/2009 | EP2010662A2 Novel gene disruptions, compositions and methods relating thereto |
| 01/07/2009 | EP2010572A1 Compositions comprising hpv polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer |
| 01/07/2009 | EP2010571A2 Humanized c-kit antibody |
| 01/07/2009 | EP2010570A2 Therapy against cathepsin s |
| 01/07/2009 | EP2010569A2 Human antibodies specific for gastrin materials and methods |
| 01/07/2009 | EP2010567A2 Antibody compositions and methods for treatment of neoplastic disease |
| 01/07/2009 | EP2010566A2 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| 01/07/2009 | EP2010562A1 Novel polypeptides inducing dendritic cell migration, as well as medicines and pharmaceutical compositions containing same |
| 01/07/2009 | EP2010517A1 Vaccine against nicotine addiction |
| 01/07/2009 | EP2010216A2 Mycobacterial immunotherapy for cancer treatment |
| 01/07/2009 | EP2010215A2 Uses and compositions for treatment of crohn's disease |
| 01/07/2009 | EP2010214A2 Uses and compositions for treatment of rheumatoid arthritis |
| 01/07/2009 | EP2010213A2 Uses and compositions for treatment of juvenile rheumatoid arthritis |
| 01/07/2009 | EP2010212A2 Anti ku70 internalizing antibodies |
| 01/07/2009 | EP2010210A2 Vaccine for avian influenza and methods of use |
| 01/07/2009 | EP2010209A2 Immunogenic wt-1 peptides and methods of use thereof |
| 01/07/2009 | EP2010207A2 Compositions and methods relating to modulation of immune system components |
| 01/07/2009 | EP2010205A2 Methods for increasing the size of animals using needleless delivery constructs |
| 01/07/2009 | EP2010201A1 Hcv vaccinations |
| 01/07/2009 | EP2010176A2 Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
| 01/07/2009 | EP1743651B1 Vaccine compositions which are obtained from streptomyces |
| 01/07/2009 | EP1689872B1 Promoters for expression in modified vaccinia virus ankara |
| 01/07/2009 | EP1644492B1 Modified recombinant vaccinia viruses, uses thereof |
| 01/07/2009 | EP1629002B1 Methods for synthesizing conformationally constrained peptides, peptidometics and the use thereof as synthetic vaccines |
| 01/07/2009 | EP1511771B1 Anti-aurora-a monoclonal antibody, method for obtaining same, and uses thereof for diagnosing and treating cancers |
| 01/07/2009 | EP1501531B1 Method for treating anxiety in older subjects |
| 01/07/2009 | EP1496942B1 Microparticles comprising carbohydrate beads covalently linked with allergen derived from plant pollen |
| 01/07/2009 | EP1476197B1 Synthesis of lipopolysaccharide-protein conjugate vaccines via the lipid a region following removal of the glycosidic phosphate residue |
| 01/07/2009 | EP1425297B1 Isolation of neural stem cells using gangliosides and other surface markers |
| 01/07/2009 | EP1409684B1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 01/07/2009 | EP1407008B1 Influenza vaccine composition |
| 01/07/2009 | EP1385545B1 Humanized antibodies recognizing the beta-amyloid peptide |
| 01/07/2009 | EP1320381B1 New immunogenic complex |
| 01/07/2009 | EP1317559B1 Dna transfection system for the generation of infectious negative strand rna virus |
| 01/07/2009 | EP1309348B1 Prophylactic and therapeutic monoclonal antibodies against vaccinia virus antigens |
| 01/07/2009 | EP1257290B1 Method for antigen-specific stimulation of t-lymphocytes with synthetic peptide libraries |
| 01/07/2009 | EP1223973B1 Method of expressing antigens on the surface of antigen presenting cells by photochemical internalization |
| 01/07/2009 | EP1212423B1 Identification of the domain of plasmodium falciparum erythrocyte membrane protein 1 (pfemp1) that mediates adhesion to chondroitin sulfate a |
| 01/07/2009 | EP1204425B1 Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein |
| 01/07/2009 | EP1200590B1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 01/07/2009 | EP1198581B1 Method for reducing the antigenicity of adeno-associated virus structural protein |
| 01/07/2009 | EP1127065B1 Chlamydia antigen and corresponding dna fragments and uses thereof |
| 01/07/2009 | EP1103564B1 Cancer antigens based on tumor suppressor gene wt1 product |
| 01/07/2009 | EP1062245B1 A method of preparing products comprising inactivated yeasts or moulds and active vhh-type antibodies |
| 01/07/2009 | EP1012293B1 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 01/07/2009 | EP1003879B1 Antigen constructs useful in the detection and differentiation of antibodies to hiv |
| 01/07/2009 | EP0980389B1 Antigen |
| 01/07/2009 | EP0971693B1 Method of making microencapsulated dna for vaccination and gene therapy |
| 01/07/2009 | EP0966537B1 Fasciola hepatica vaccines |
| 01/07/2009 | EP0870046B1 Recombinant live vaccine containing feline herpes virus type 1, particularly for treating feline infectious peritonitis |
| 01/07/2009 | EP0662827B2 Diagnostic methods and pharmaceutical compositions based on notch proteins and nucleic acids |
| 01/07/2009 | CN101341171A Therapeutic agent |
| 01/07/2009 | CN101340929A Compositions and methods for the treatment and prevention of fibrotic, inflammatory, and neovascularization conditions of the eye |
| 01/07/2009 | CN101340892A Use of a liquid allergy vaccine formulation for oromucosal administration |
| 01/07/2009 | CN101337990A Humanized neutralizing antibody against rabies virus, method for preparing same and use |
| 01/07/2009 | CN101337070A Freeze-dried attenuated live vaccine for hepatitis A and its preparing process |
| 01/07/2009 | CN101337069A Compound plague vaccine and preparation method thereof |
| 01/07/2009 | CN101336982A Composition for preventing alopecia and/or promoting hair regeneration |
| 01/07/2009 | CN100448994C Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, proteins encoded, and uses thereof |
| 01/07/2009 | CN100448893C Humanized antibodies that recognize beta amyloid peptide |
| 01/07/2009 | CN100448892C Antitumour vascular endothelial growth factor receptor VEGF-R antigen and its coding gene and application |
| 01/07/2009 | CN100448486C Use of P2Y purinergic receptor expression for identifying preneoplastic and neoplastic states |
| 01/07/2009 | CN100448485C Vaccine |
| 01/06/2009 | US7473772 Chimeric GB virus B (GBV-B) |
| 01/06/2009 | US7473771 Nucleotide sequences coding recombinant protein for use in prevention and treatment of hyperphosphatemia |
| 01/06/2009 | US7473762 solid phase synthesis; for diagnosis/treatment/prophyaxis; animal models; genetic engineering |
| 01/06/2009 | US7473686 Thrombopoietin mimetics |
| 01/06/2009 | US7473559 Method for measuring the content of a botulinum toxin in a formulation |
| 01/06/2009 | US7473536 To increase the titer of avipoxviruses produced from cells after infection of cells with the avipoxvirus, wherein the host range gene is expressed in cells |
| 01/06/2009 | US7473429 Method for treatment of laminitis in animals |
| 01/06/2009 | US7473428 Vaccination of pigs against disease by administering a first recombinant porcine adenovirus vector stably expressing a heterologous nucleotide sequence encoding the antigenic determinant of the disease, preferably Hog Cholera Virus or Pseudorabies virus |
| 01/06/2009 | US7473425 Remedies for ischemic disease |
| 01/06/2009 | US7473424 Comprises immunoglobulin for use in diagnosis, prevention and treatment of hemorrhagic viral infection; viricides and immunotherapy |
| 01/06/2009 | US7473423 Human IgM antibodies, and diagnostic and therapeutic uses thereof particularly in the central nervous system |
| 01/06/2009 | US7473422 Monoclonal antibody which recognizes polypeptide comprising heme binding motif and sequencially related to cytochrome p450 for use in preventing hydroxylation of retinoic acid and treating cell proliferative and skin disorders |
| 01/06/2009 | US7473421 Comprises nucleotide sequences coding immunoglobulin which binds chemokine receptor 2 for use in the treatment and prevention of restenosis |
| 01/06/2009 | US7473247 Intradermal delivery of vaccines and gene therapeutic agents via microcannula |
| 01/06/2009 | CA2380231C Conditionally controlled, attenuated hiv vaccine |
| 01/06/2009 | CA2340921C Use of taxanes to treat brain cancer |
| 01/06/2009 | CA2305341C Stabilization of envelope glycoprotein trimers by disulfide bonds introduced into a gp41 glycoprotein ectodomain |
| 01/06/2009 | CA2268138C Mycosis vaccines |
| 01/06/2009 | CA2245584C Recombinant expression of s-layer proteins |
| 01/06/2009 | CA2181590C Peptomers with enhanced immunogenicity |
| 01/06/2009 | CA2158446C Nucleic acid coding for a tumor rejection antigen precursor |
| 01/06/2009 | CA2149770C Detection of hypoxia |
| 01/06/2009 | CA2117490C Purified vacuolating toxin from helicobacter pylori and methods to use same |
| 01/06/2009 | CA1341588C Human ifn-beta2/i1-6, its purification and use |
| 01/01/2009 | US20090007280 Ange gene in atopy |
| 01/01/2009 | US20090004733 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides, and uses thereof |
| 01/01/2009 | US20090004723 Methods and Compositions Concerning Poxviruses and Cancer |
| 01/01/2009 | US20090004722 bovine parainfluenza virus (bPIV) cDNA or RNA which may be used to express heterologous gene products; tumor antigens; cancer |
| 01/01/2009 | US20090004271 Morselized foam for wound treatment |
| 01/01/2009 | US20090004264 Methods for treating and ameliorating the symptons of inflammatory bowel diseases |
| 01/01/2009 | US20090004240 Implants with a phosphazene-containing coating |